PHARMA INDUSTRY PUSHES FOR STREAMLINED REGULATION AT EU-US FREE TRADE TALKS
July 5th, 2014
Including pharmaceuticals within a European Union (EU)-US free trade agreement could cut administrative costs dramatically for pharmaceutical companies and allow new drugs to reach the market more rapidly, according to industry representatives.Speaking at a ‘stakeholders’ forum with official negotiators in Brussels on Wednesday, (July 16), executives said they would like the planned Transatlantic Trade & Investment Partnership (TTIP) to boost EU-US regulatory compatibility, increasing market access and intellectual property (IP) guarantees.But, as EU and ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.